Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03776747 · ClinicalTrials.gov registry record · Phase 4
Repeatability in Hyperpolarized 3-Helium With MRI
A Phase 4 study, sponsored by Eric A. Hoffman.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT03776747 is a Phase 4 study that has completed, run by Eric A. Hoffman. The registered enrollment target is 18 participants.
The verdict
NCT03776747, a Phase 4 study, has completed, sponsored by Eric A. Hoffman.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
The main purpose of this study is to assess and test the reproducibility and results of hyperpolarized 3-Helium gas as a contrast agent with Magnetic Resonance Imaging (MRI) of the lungs in healthy adult subjects.
Interventions
- DRUG Prone hyperpolarized 3 helium gas scan
- DRUG Supine hyperpolarized 3 helium gas scan
- DIAGNOSTIC_TEST Vitals
- DIAGNOSTIC_TEST Pulmonary Function Tests
- DIAGNOSTIC_TEST Initial protocol MRI scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-07-22 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03776747
The ClinicalTrials.gov registry entry for NCT03776747 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eric A. Hoffman, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Prone hyperpolarized 3 helium gas scan is the first listed.
NCT03776747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03776747 about?
NCT03776747 is a clinical study titled "Repeatability in Hyperpolarized 3-Helium With MRI". The main purpose of this study is to assess and test the reproducibility and results of hyperpolarized 3-Helium gas as a contrast agent with Magnetic Resonance Imaging (MRI) of the lungs in healthy adult subjects.
What is the current status of trial NCT03776747?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2008-07-22. Estimated completion is 2012-06.
What interventions are being tested in trial NCT03776747?
The interventions under investigation include: Prone hyperpolarized 3 helium gas scan (DRUG), Supine hyperpolarized 3 helium gas scan (DRUG), Vitals (DIAGNOSTIC_TEST), Pulmonary Function Tests (DIAGNOSTIC_TEST), Initial protocol MRI scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03776747?
This trial is sponsored by Eric A. Hoffman, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.